Exelixis (EXEL) Other Non-Current Liabilities (2010 - 2026)

Exelixis' (EXEL) quarterly Other Non-Current Liabilities came in at $117.3 million in Q2 2026, down 2.22% year-on-year from $120.0 million in Q2 2025, and up 12.36% quarter-over-quarter from $104.4 million in Q1 2026.

Exelixis (EXEL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Exelixis' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $117.3 million for Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 2.22% year-over-year to $117.3 million in Q2 2026; TTM through Apr 2026 was $117.3 million, a 2.22% decrease from a year earlier, with the FY2026 full-year figure at $104.4 million, down 4.11% from the prior year.
  • Other Non-Current Liabilities climbed to $117.3 million in Q2 2026 per EXEL's latest filing, from $104.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $128.6 million in Q3 2025 and bottomed at $1.9 million in Q3 2022.
  • The 5-year median for Other Non-Current Liabilities is $96.1 million (2024), against an average of $82.1 million.
  • Across the five-year window, Other Non-Current Liabilities tumbled 53.35% in 2022 and surged 3129.35% in 2023, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $68.5 million in 2022, then surged by 37.49% to $94.2 million in 2023, then rose by 1.95% to $96.1 million in 2024, then climbed by 17.22% to $112.6 million in 2025, then climbed by 4.19% to $117.3 million in 2026.
  • Per Business Quant, the three latest EXEL Other Non-Current Liabilities figures stand at $117.3 million (Q2 2026), $104.4 million (Q1 2026), and $112.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 117.33 Mn
Jan 2, 2026 104.42 Mn
Oct 3, 2025 112.61 Mn
Jul 4, 2025 128.59 Mn
Apr 4, 2025 120.00 Mn
Jan 3, 2025 108.90 Mn
Sep 27, 2024 96.07 Mn
Jun 28, 2024 109.67 Mn
Mar 29, 2024 101.27 Mn
Dec 29, 2023 94.22 Mn
Sep 29, 2023 61.62 Mn
Jun 30, 2023 73.50 Mn
Mar 31, 2023 67.38 Mn
Dec 30, 2022 68.53 Mn
Sep 30, 2022 1.91 Mn
Jul 1, 2022 17.40 Mn
Apr 1, 2022 12.52 Mn
Dec 31, 2021 8.02 Mn
Oct 1, 2021 4.09 Mn
Jul 2, 2021 7.07 Mn